Taaleri’s bioindustry fund invests in Enifer, a company producing mycoprotein
TAALERI BIOINDUSTRY PRESS RELEASE 23 MAY 2024 AT 8:45 (EEST)
Taaleri’s bioindustry fund invests in Enifer, a company producing mycoprotein
Taaleri Bioindustry Fund I invests in Enifer, a Finnish company producing fungi-based mycoprotein. Investment enables Enifer to construct a new mycoprotein factory in Kantvik, Kirkkonummi, Finland.
Enifer was founded in 2020 to develop and commercialize the proprietary PEKILO® technology further. Mycoprotein is produced by cultivating a specific species of fungus in a fermentation process that is not too distinct from brewing beer or making soy sauce. The PEKILO® fermentation process was originally developed in Finland in the 1970s and used by the forest industry.
Mycoprotein is a sustainable alternative to animal and some soy proteins. This alternative protein has a significant positive contribution to biodiversity because the production process does not require direct land use as many other plant and animal proteins do. The production of mycoprotein also has a low carbon footprint and requires minimal water use. PEKILO® protein’s carbon footprint is 2.8 kgCO2e per kg of protein, compared to 6.5–26.0 kgCO2e per kg of animal protein (chicken, pork, or beef). Its footprint is also small compared to 6.0 kgCO2e per kg of soy protein.
The investment is Taaleri Bioindustry Fund I’s fourth investment. The fund invests in industrial-scale production facilities and companies that can accelerate the scaling of bioindustry production. The fund has already invested in Colombier, Nordtreat and Nordic Bioproducts Group. Colombier produces ecological packaging, Nordtreat produces bio-based flame retardants, and Nordic Bioproducts Group produces cellulose-based materials with a high processing value.
Taaleri Bioindustry Fund I complies with Article 9 of the EU Sustainable Finance Disclosure Regulation and is as such a so called dark green fund that only makes sustainable investments in projects that, for example, contribute substantially to climate change mitigation. The fund has raised over EUR 100 million. The state-owned special-assignment company, the Finnish Climate Fund, is the fund’s anchor investor.
“We are very happy to start cooperation with Enifer. We believe that there is an increased need for alternative proteins as the global population grows. Demand is also supported globally by environmental and ethical considerations. Taaleri Bioindustry Fund I’s investment enables commercial scale production. We are confident in Enifer’s opportunities to expand,” comments Tero Saarno, Managing Director, Taaleri Bioindustry.
“At Enifer, we’re extremely excited to announce the kick-off of our first factory investment project. For over half a century, Kantvik has been at the heart of Finnish bioindustries, and I could not think of a better location to bring PEKILO® fermentation back to life. I would like to thank our new investors, in particular Taaleri Bioindustry and the Finnish Climate Fund, for joining us in our mission. Mycoprotein is the missing ingredient for a more sustainable food chain – the facility in Kantvik serves as a key steppingstone on our path to making mycoprotein a cornerstone of protein supply, with several future factories already being planned,” says Simo Ellilä, CEO and co-founder of Enifer.
Taaleri’s vision is to become a leading investment manager operating internationally in bioindustry and renewable energy.
For further information, please contact:
Tero Saarno, Managing Director, Taaleri Bioindustry, +358 50 373 1923, tero.saarno@taaleri.com
Simo Ellilä, CEO, Enifer, +358 40 567 5786, simo.ellila@enifer.com
Taaleri in brief
Taaleri is a Nordic investment and asset manager that focuses on businesses with industrial-scale opportunities within bioindustry and renewable energy. We create value by combining extensive know-how, deep expertise, entrepreneurship and capital through both funds under management and direct investments. We have been a signatory of the UN Principles for Responsible Investment (UNPRI) since 2010, and we joined the Net Zero Asset Managers initiative in 2021. Taaleri’s vision is to become a leading investment manager operating internationally in bioindustry and renewable energy.
Taaleri has EUR 2.6 bn of assets under management in its private equity funds and co-investments. The company has approximately 125 employees. Taaleri Plc is listed on Nasdaq Helsinki.
Enifer in brief
Enifer, a spin-off company from VTT Technical Research Centre of Finland, was founded by five scientists in 2020 to develop and commercialize the proprietary PEKILO® technology further. A process originally developed and used by the Finnish forest industry at a commercial scale, the PEKILO® technology enables the biotechnological conversion of dilute side streams into a high-protein ingredient, PEKILO® mycoprotein.
Enifer already has ongoing partnerships with big global companies in the feed and food industries, such as Skretting, the global aquafeed division of Nutreco, Purina for pet food, and Valio for consumer food products.
Images
Alternative languages
Subscribe to releases from Taaleri Bioteollisuus
Subscribe to all the latest releases from Taaleri Bioteollisuus by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Taaleri Bioteollisuus
Taaleri’s bioindustry fund invests in Nordic Bioproducts Group, a company producing cellulose-based materials with a high processing value30.3.2023 09:15:00 EEST | Press release
TAALERI BIOINDUSTRY PRESS RELEASE 30 MARCH 2023 AT 9:15 (EEST) Taaleri’s bioindustry fund invests in Nordic Bioproducts Group, a company producing cellulose-based materials with a high processing value Taaleri’s bioindustry fund invests in Nordic Bioproducts Group, a Finnish company producing cellulose-based materials with a high processing value. The purpose of the investment is to strengthen Nordic Bioproducts Groups’s (NBG) growth and expansion. Nordic Bioproducts Group was founded in 2019 to develop new biomaterials based on the patented AaltoCell technology. The cellulose hybrids developed and manufactured by NBG are processed from Finnish forest fibres and cellulose-containing industrial and agricultural side and waste streams. The company aims to bring to the market environmentally more sustainable and low-emissions alternatives to fossil raw materials and harmful chemicals. For example, in the textile industry, pulp-based fibres can replace cotton and artificial fibres, and in
Taalerin bioteollisuusrahasto sijoittaa korkean jalostusarvon selluloosapohjaisia materiaaleja valmistavaan Nordic Bioproducts Groupiin30.3.2023 09:15:00 EEST | Tiedote
TAALERI BIOTEOLLISUUS LEHDISTÖTIEDOTE 30.3.2023 klo 9.15 Taalerin bioteollisuusrahasto sijoittaa korkean jalostusarvon selluloosapohjaisia materiaaleja valmistavaan Nordic Bioproducts Groupiin Taalerin bioteollisuuteen keskittyvä rahasto Taaleri Bioteollisuus I sijoittaa suomalaiseen korkean jalostusarvon selluloosapohjaisia materiaaleja valmistavaan Nordic Bioproducts Groupiin. Sijoituksella on tarkoitus vahvistaa Nordic Bioproducts Groupin (NBG) kasvua ja laajentumista. Nordic Bioproducts Group perustettiin vuonna 2019 kehittämään uusia biomateriaaleja, jotka perustuvat patentoituun AaltoCell-teknologiaan. NBG:n kehittämät ja valmistamat selluloosahybridit on jalostettu kotimaisista metsäkuiduista sekä selluloosaa sisältävistä teollisuuden ja maatalouden sivu- ja jätevirroista. Yhtiö pyrkii tuomaan markkinoille ympäristön kannalta kestävämpiä ja vähäpäästöisempiä vaihtoehtoja fossiilisille raaka-aineille ja haitallisille kemikaaleille. Esimerkiksi tekstiiliteollisuudessa sellupohjais
Taaleri’s first bioindustry fund invests in Nordtreat, a company producing bio-based flame retardants22.11.2022 09:15:00 EET | Press release
TAALERI BIOINDUSTRY PRESS RELEASE 22 NOVEMBER 2022 AT 9:15 (EET) Taaleri’s first bioindustry fund invests in Nordtreat, a company producing bio-based flame retardants Taaleri’s first bioindustry fund invests in Nordtreat, a Finnish company producing bio-based, environmentally friendly and non-harmful flame-retardants. The purpose of the investment is to strengthen Nordtreat's growth and expansion. Founded in 2015, Nordtreat manufactures bio-based flame-retardant chemicals for building materials made from renewable raw materials. The company has developed and commercialized fire retardants, especially for wood construction. The products are based on the company's patented fire protection technology. Nordtreat's products replace traditional flame-retardants that contain compounds that are harmful to humans and the environment, such as boric acid, formaldehyde, and ammonia. The investment is Taaleri Bioindustry I Fund’s second investment. The fund invests in industrial-scale production fa
Taalerin ensimmäinen bioteollisuusrahasto sijoittaa biopohjaisia palosuoja-aineita valmistavaan Nordtreat-yhtiöön22.11.2022 09:15:00 EET | Tiedote
TAALERI BIOTEOLLISUUS LEHDISTÖTIEDOTE 22.11.2022 klo 9.15 Taalerin ensimmäinen bioteollisuusrahasto sijoittaa biopohjaisia palosuoja-aineita valmistavaan Nordtreat-yhtiöön Taalerin ensimmäinen bioteollisuuteen keskittyvä rahasto Taaleri Bioteollisuus I sijoittaa suomalaiseen biopohjaisia, ympäristöystävällisiä palosuoja-aineita valmistavaan Nordtreat-yhtiöön. Sijoituksella on tarkoitus vahvistaa Nordtreatin kasvua ja laajentumista. Vuonna 2015 perustettu Nordtreat valmistaa biopohjaisia palosuojakemikaaleja uusiutuvista raaka-aineista valmistettaviin rakennusmateriaaleihin. Yhtiö on kehittänyt ja kaupallistanut palosuoja-aineita erityisesti puurakentamiseen. Tuotteet perustuvat yhtiön kehittämään patentoituun palosuojausteknologiaan. Nordtreatin tuotteet korvaavat perinteisiä palosuoja-aineita, jotka sisältävät ihmisille ja ympäristölle haitallisia yhdisteitä kuten boorihappoa, formaldehydia ja ammoniakkia. Sijoitus Nordtreatiin on Taaleri Bioteollisuus I -rahaston toinen sijoitus. Rah
Taaleri’s first bioindustry fund invests in Colombier, a company producing ecological packaging16.11.2022 09:15:00 EET | Press release
TAALERI BIOINDUSTRY PRESS RELEASE 16 NOVEMBER 2022 AT 9:15 (EET) Taaleri’s first bioindustry fund invests in Colombier, a company producing ecological packaging Taaleri’s first bioindustry fund invests in Colombier, a company producing ecological packaging. The purpose of the investment is to expand Colombier Finland’s Ecological Packaging plant producing innovative packaging materials in Pyhtää, Finland. Colombier Finland is part of the international Colombier Group, which has 50 years of experience in paper and cardboard products. Today, the company offers its customers alternatives to plastic packaging. In addition to Finland, the group has subsidiaries in the Netherlands, Great Britain and Spain. The investment is Taaleri Bioindustry I Fund’s first investment. The fund invests in industrial-scale production facilities and companies that can accelerate the scaling of bioindustry production. Products can be, for example, bio- and recycled fibers, organic fertilizers, functional bioma
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom